ChemLex Raises $45M and Opens Self-Driving Drug Discovery Lab in Singapore

December 08, 2025
ChemLex has raised $45 million and established its global headquarters and self-driving laboratory in Singapore to accelerate AI-driven chemical discovery for pharmaceuticals.
ChemLex Raises $45M and Opens Self-Driving Drug Discovery Lab in Singapore

ChemLex has raised USD 45 million and established its global headquarters and self-driving laboratory in Singapore, announced in a press release. The funding round was led by Granite Asia and will support the hiring of additional engineers and chemists to expand the company’s research capabilities.

Founded in 2022, ChemLex develops AI-powered systems that accelerate chemical discovery in the pharmaceutical industry. Its autonomous chemistry platform operates continuously, conducting and analyzing experiments in real time to shorten the synthesis and optimization process from months to weeks.

The company also signed a memorandum of understanding with Singapore’s Experimental Drug Development Centre to advance small molecule drug discovery through automation. ChemLex’s move aligns with efforts by the Singapore Economic Development Board to strengthen the country’s life sciences and deep tech ecosystem.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

12/05
Marvell to Acquire Celestial AI for $3.25 Billion to Advance Optical Connectivity for AI Data Centers
12/04
Clipbook Raises $3.3 Million Seed Round to Expand AI Platform for Communications
12/04
Tata Communications Acquires Majority Stake in Commotion to Advance AI Integration
12/04
Wayve Acquires Quality Match to Boost Data Quality for Autonomous Driving
12/04
OpenAI to Acquire Neptune for AI Model Training Tools

More from: Life Sciences

12/08
Michael J. Fox Foundation Launches Target Validation Program for Parkinson’s Therapies
12/03
FDA Introduces Agentic AI Platform for Staff Workflows
12/03
Medint Study Finds AI Misses Key Nuances in Complex Clinical Decisions
12/03
Linus Health to Present AI Tools for Early Alzheimer’s Detection at CTAD 2025
12/03
Dastify Solutions Report Predicts 40% Drop in Medical Claim Denials with AI in 2025

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like